Demo Sign up Log In

Ligand Pharmaceuticals Inc (LGND)

Operating Expenses

$185.49M

TTM · Period ending: Jun 30, 2026 · USD

LGND Operating Expenses

Latest reported$185.49Mperiod endingJun 30, 2026

Latest reported$185.49Mperiod endingJun 30, 2026

LGND TTM Operating Expenses ($9.50M → $185.49M)

TTM operating expenses

High-resolution chart · PNG

LGND operating expenses history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Ligand Pharmaceuticals Inc Operating Expenses — Trailing twelve months (TTM) (USD)
Period ending	Operating Expenses (USD)
Jun 30, 2001	87,807,000
Mar 31, 2001	91,158,000
Dec 31, 2000	92,373,000
Sep 30, 2000	95,593,000
Jun 30, 2000	95,478,000
Mar 31, 2000	95,313,000
Dec 31, 1999	94,100,000
Sep 30, 1999	106,000,000
Jun 30, 1999	102,800,000
Mar 31, 1999	99,000,000
Dec 31, 1998	95,000,000
Sep 30, 1998	90,900,000
Jun 30, 1998	91,300,000
Mar 31, 1998	90,500,000
Dec 31, 1997	92,200,000
Sep 30, 1997	88,500,000
Jun 30, 1997	87,200,000
Mar 31, 1997	84,200,000
Dec 31, 1996	79,000,000
Sep 30, 1996	72,800,000
Jun 30, 1996	66,300,000
Mar 31, 1996	47,700,000
Dec 31, 1995	41,100,000
Sep 30, 1995	28,000,000
Jun 30, 1995	14,900,000
Mar 31, 1995	16,900,000
Dec 31, 1994	9,500,000

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.